Hillhouse Investment Group

Hillhouse Investment Group, established in 2005 and headquartered in Hong Kong, is a prominent global investment management firm that focuses on private equity. The firm engages in long-term investments across various sectors, including healthcare, business services, consumer goods, industrials, and energy transition. Hillhouse partners with exceptional entrepreneurs to foster sustainable value creation within quality companies. In addition to private equity, the firm also participates in public equity, real estate, and private credit, managing capital on behalf of global institutions such as non-profit foundations, endowments, and pension funds.

Joe Gagnon

Partner

Jing Hong

Partner

Huang Liming

Partner

Michael Yi

Partner

Sean Carney

Partner and Co-Head of Global Buyout

Past deals in Series B

Sainte

Series B in 2025
Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs

ZJeagles Comsemi

Series B in 2025
ZJeagles Comsemi specializes in the design and production of optical communication chips tailored for data centers and various industrial applications. The company's product range includes high-speed optical communication VCSEL chips, high-power-density lidar VCSEL chips, and high-efficiency 3D sensing VCSEL chips. These advanced chips support critical functions in data center optical interconnection, automotive autonomous driving, and smart lighting. Additionally, ZJeagles Comsemi offers innovative LED packaging products that enhance the capabilities of consumer electronics and industrial systems. By providing comprehensive chip solutions, the company aims to empower its industry customers with essential production inputs for their technological advancements.

dinii

Series B in 2024
Dinii is a software company that specializes in creating digital ordering platforms tailored for restaurants and local take-out establishments. The company develops a mobile ordering platform that connects customers with dining options through their smartphones. Dinii's services enable restaurant businesses to streamline the online ordering process, allowing customers to easily select products, complete transactions, and receive printed invoices automatically. Additionally, the platform supports QR code ordering, enhancing the dining experience and improving operational efficiency for restaurants by increasing turnover and reducing overhead costs.

Silicon Box

Series B in 2024
Silicon Box is an advanced provider of outsourced semiconductor assembly and testing services, focusing on semiconductor integration. The company offers comprehensive capabilities in semiconductor packaging, from initial design to the final manufacturing of various chip types, including standard single chip packages and sophisticated chiplet-based systems. Its services support a wide range of applications, such as artificial intelligence, high-performance computing, electric vehicles, automotive technologies, power management, and mobile chipsets. Silicon Box aims to enhance chipset design through its manufacturing processes, which help shorten design cycles, reduce costs, and lower power consumption, ultimately delivering advanced and high-quality semiconductor interconnections to its customers.

Tenways

Series B in 2023
Tenways is a manufacturer and seller of eBikes designed to facilitate daily commuting in an effortless, speedy, and eco-friendly manner. The company focuses on creating affordable and easy-to-use bicycles that cater to a growing demand for sustainable transportation options. With a robust, vertically integrated global manufacturing and supply chain, Tenways ensures that its eBikes are not only reliable but also contribute to reducing the carbon footprint associated with traditional commuting methods.

Capcon

Series B in 2023
Capcon is a developer and manufacturer specializing in semiconductor assembly and packaging equipment. The company provides advanced products and innovative solutions tailored for the semiconductor assembly and packaging industry. Its diverse product line includes Flip-Chip Bonders, Chip-on-Wafer Bonders, Package-on-Package Bonders, Stack Die Bonders, Panel-Level Die Bonders, and Multi-Chip Die Bonders. These offerings enable clients to utilize high-precision, high-speed, and high-reliability semiconductor equipment, thereby enhancing productivity in their operations.

Hystar

Series B in 2023
Hystar is a company established in 2020 that specializes in the development of polymer electrolyte membrane electrolyzers intended for large-scale green hydrogen production. Its innovative technology features a distinctive cell design and process architecture that aims to lower electricity consumption while enhancing hydrogen output. This advancement supports professionals in addressing significant energy challenges and offers the potential to diminish greenhouse gas emissions.

Astronergy

Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.

Zilliz

Series B in 2022
Zilliz is a prominent vector database company based in San Francisco, California, founded in 2016. It specializes in developing advanced data processing platforms that leverage artificial intelligence and big data technologies. Zilliz is known for Milvus, an open-source vector database designed to facilitate the creation of AI and machine learning applications. By simplifying complex data infrastructure management, the company aims to enable organizations to harness the advantages of AI for a variety of applications, including computer vision, natural language processing, recommendation systems, and more. Zilliz supports over 1,000 organizations globally, helping them unlock insights from unstructured data while improving query performance through GPU hardware acceleration. Its investor backing includes notable firms such as Hillhouse Capital and Temasek's Pavilion Capital, underscoring its position in the AI and data management sectors.

Jinjiang Electronic Technology

Series B in 2022
Jinjiang Electronic Technology is a med-tech company focused on the research and development as well as the manufacture of advanced medical equipment designed to enhance patient care in the field of cardiac electrophysiology. The company offers a range of innovative products, including a 3D cardiac mapping system, electrophysiology recording system, cardiac RF ablation generator, and irrigation pump. These devices provide comprehensive solutions aimed at diagnosing and treating arrhythmias, ultimately improving the quality of life for patients with heart conditions.

Proton Bio

Series B in 2022
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To address clients' therapeutic product demands at the pre-clinical, clinical, and commercial stages, the firm offers end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Maxvax Health

Series B in 2022
MAXVAX is focused on the development and commercialization of innovative vaccines, specifically targeting viral diseases such as rotavirus, shingles, and herpes. The company's technology is designed to enhance treatment options within the biotechnology industry, enabling healthcare professionals to offer improved solutions for patients suffering from these infections. By concentrating on effective vaccine development, MAXVAX aims to contribute significantly to the healthcare sector and improve patient outcomes.

Semitech

Series B in 2022
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.

Style3D

Series B in 2022
Style3D is a software and service ecosystem for all fashion that enables designers and businesses to work on real-time 3D simulation outperforming their productivity and creativity while reaching higher sustainability.

Qingyun Zhitong

Series B in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.

GritWorld

Series B in 2022
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

JD Property

Series B in 2022
JD Property is an infrastructure asset manager that specializes in logistics real estate development, leasing, and management. The company offers a range of services, including comprehensive property services and asset management. It focuses on developing modern standard warehouses and integrated intelligent industrial parks, along with data centers and photovoltaic new energy solutions. Through its investment development and diversified value-added services, JD Property aims to provide comprehensive infrastructure construction and operational solutions for various industries.

FAIR

Series B in 2022
FAIR is a collaborative robot company that has research and development and manufacturing capabilities for robot core components and complete machine systems such as robot controllers, precision reducers, and servo systems.

Enkris Semiconductors

Series B in 2022
Enkris Semiconductors specializes in the development of high-quality gallium nitride (GaN) epitaxial wafers tailored for power electronics and micro-display applications. The company offers a range of material solutions, including GaN-on-Si, GaN-on-SiC, GaN-on-Sapphire, and GaN-on-GaN, which are designed to support the next generation of RF devices and micro-LED technology. By utilizing CMOS-compatible technology, Enkris Semiconductors aims to produce reliable and cost-effective GaN materials, allowing businesses in power electronics and micro-display sectors to enhance their product performance and efficiency. Through its focus on innovation and quality, the company is positioned to meet the growing demands of these advanced technological fields.

Deep View Technology

Series B in 2022
Deep View Technology specializes in motion capture and the development of augmented reality (AR) and virtual reality (VR) applications. The company focuses on research and development related to three-dimensional computer vision algorithms. Utilizing wearable devices, Deep View Technology's services enable the identification of body part gestures, allowing clients to capture human postures in real time. This innovative approach enhances interactive experiences in virtual environments.

Bluepha

Series B in 2022
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.

LePure Biotech

Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.

DP Technology

Series B in 2021
DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D. DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trained large science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.

CertiK

Series B in 2021
CertiK, established in 2018, is a leading blockchain security company. Headquartered in New York with offices in Beijing, Seoul, and Seattle, it specializes in securing smart contracts and blockchain ecosystems. CertiK offers security audits, penetration testing, and custom formal verification services, utilizing AI technology to protect and monitor blockchain protocols and smart contracts in real-time. The company, founded by professors from Yale and Columbia Universities, aims to secure the web3 world by applying cutting-edge academic innovations to enterprise-level applications.

GritWorld

Series B in 2021
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

Js Designs

Series B in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.

Datacloak

Series B in 2021
Datacloak, Inc. is a Shenzhen-based company that specializes in developing a computing platform focused on data security and privacy protection. The firm offers solutions that enable enterprises to store, access, and share data securely, employing technologies that facilitate secure communication between devices and company networks. Datacloak's offerings include enterprise computing, cloud computing, and artificial intelligence, which together create software-defined adaptive computing environments. This technology supports a decentralized approach to data storage, management, and transmission, allowing organizations to enhance their operational capabilities by integrating private and hybrid cloud environments.

Etern

Series B in 2021
Etern is developing small molecule drugs for protein liquid-liquid phase separation, using the LLPS platform for AI-enabled target discovery, high-throughput screening, and optimization. This could open new treatment strategies for major diseases.

Qmai.cn

Series B in 2021
Qmai.cn is an enterprise services company based in Hefei that specializes in developing a business management platform tailored for retailers and chain store operators. The platform offers a range of operational solutions, including enterprise smart retail features, digital store operations, and payment acquiring services. By providing these tools, Qmai.cn enables retailers to enhance user connections and streamline their operations through digitalization.

CertiK

Series B in 2021
CertiK, established in 2018, is a leading blockchain security company. Headquartered in New York with offices in Beijing, Seoul, and Seattle, it specializes in securing smart contracts and blockchain ecosystems. CertiK offers security audits, penetration testing, and custom formal verification services, utilizing AI technology to protect and monitor blockchain protocols and smart contracts in real-time. The company, founded by professors from Yale and Columbia Universities, aims to secure the web3 world by applying cutting-edge academic innovations to enterprise-level applications.

Hangzhou Stupa Network Technology

Series B in 2021
PerfMa (Hangzhou Bumma Network Technology Co., Ltd.) is committed to providing enterprises with comprehensive solutions in the field of performance optimization, and establishes a complete set of performance guarantee system from performance pressure measurement, monitoring, positioning to optimization to ensure that the application system is under rapid iteration. Code quality and stability. At the same time, it will improve the research and development efficiency, save resource costs, lower the recruitment threshold, enhance the overall technical strength, and help enterprises to develop at a high speed

Nobell Foods

Series B in 2021
Nobell Foods is a biotech company based in San Francisco, California, that specializes in developing and producing animal-based food substitutes using plant materials. Founded in 2016, the company aims to transform plants into bioreactors to generate protein, unlocking their potential to create innovative food alternatives. By focusing on plant-based solutions, Nobell Foods seeks to provide sustainable options that can replace traditional animal products, contributing to a more environmentally friendly food system.

VirtAI Tech

Series B in 2021
VirtAI Tech specializes in the development of innovative GPU resource pooling technology and AI computing power distribution systems designed for data centers. Its flagship product, the Orion AI computing platform, enables customers to create datacenter-class AI accelerator resource pools, allowing user applications to seamlessly share and utilize AI accelerators across servers without modification. This technology significantly enhances resource utilization and simplifies the deployment of applications. By focusing on advanced virtual graphics processing units, VirtAI Tech ensures that computations performed on physical GPUs can be executed with minimal performance loss, thereby optimizing the efficiency of computing power within data centers. The platform has attracted interest from various artificial intelligence, Internet, and public cloud companies.

Qitan Technology

Series B in 2021
Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Lingxing

Series B in 2021
Lingxing is a cross-border e-commerce SaaS service provider of ERP functional software products and solutions.

SmartAHC

Series B in 2021
SmartAHC, incubated by Nanyang Technological University, focuses on intelligent farming solutions specifically for livestock management. The company develops innovative pig wearables and a tracking system that automatically and remotely monitor the health and ovulation periods of pigs. This technology allows farmers to reduce labor costs while enhancing the care and management of their livestock. By providing tools for breeding, inventory counting, growth monitoring, and behavioral analysis, SmartAHC aims to improve the overall efficiency of farming operations. The company has garnered support from a range of prominent investors, reflecting its potential impact on the agriculture sector.

Star Charge

Series B in 2021
Star Charge specializes in the development and manufacturing of charging equipment specifically for new energy vehicles. The company serves a global clientele by providing comprehensive charging infrastructures, platforms, and data operations, leveraging Internet of Things technologies. Star Charge's offerings encompass various aspects of electric vehicle support, including vehicle sales, private and public charging solutions, and financial services. By focusing on these areas, the company aims to enhance energy efficiency, facilitate structural adjustments in energy utilization, promote energy conservation, and mitigate pollution emissions.

RoboticPlus.AI

Series B in 2021
RoboticPlus.AI is a robotics company that focuses on advancing architectural technology by delivering intelligent robotic solutions tailored for the construction sector. It specializes in developing robotics technology that addresses the demands of mass customization within the industry. The company's products integrate design, computer science, artificial intelligence, and industrial manufacturing to enhance operational efficiency. By employing intelligent programming, digital design, and human-computer interaction, RoboticPlus.AI's robots enable customers to improve work efficiency and reduce labor costs, thereby transforming traditional construction practices.

Bioheng

Series B in 2021
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.

Bluepha

Series B in 2021
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.

LakeShore Biopharma

Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.

Cryofocus Biotech

Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Agile Robots

Series B in 2021
Agile Robots AG is a German company, founded in 2018 and headquartered in Gilching, with an additional office in Beijing, China. The company specializes in developing advanced robotic solutions that integrate artificial intelligence to enhance manufacturing, medical assistance, and service robotics. Its core offerings include a lightweight robotic arm featuring seven degrees of freedom and a general-purpose robot controller, designed for versatility in various applications. Agile Robots also provides a sophisticated robot vision system and scalable robotics optimized for seamless integration of perception, intelligence, and actuation. These systems are equipped with ultra-sensitive joint torque sensors, enabling them to detect and respond to interactions with human users and their environments, effectively bridging the gap between artificial intelligence and the physical world.

Targeting One

Series B in 2021
Beijing Targeting One Technology Co., Ltd. specializes in the development and production of biomedical instruments and consumables, focusing on in vitro diagnostic reagents for precision medicine, health management, and life science research. Established in 2015 and based in Beijing, the company offers a range of products including sample preparation apparatus, biochip readers, digital PCR supplies, and genetic testing kits. Its digital PCR solutions play a crucial role in medical diagnostics, with applications in transplant rejection monitoring, targeted sequencing, tumor liquid biopsy, and non-invasive prenatal screening. Targeting One aims to enhance gene testing and precision medicine through its innovative technologies and comprehensive offerings.

Core Medical Technology

Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

EMQ Technologies

Series B in 2020
EMQ is an open-source IoT data infrastructure software provider, delivering the world's leading cloud-native MQTT-based IoT messaging platform and streaming database, providing a one-stop cloud-native solution for real-time IoT data connection, movement, processing and analytics, from edge to cloud to multi-cloud. As a global organization, EMQ located its R&D center in Stockholm, Sweden, and has 10+ offices throughout the Americas, Europe, and the Asia-Pacific region. The flagship product EMQX is adopted by more than 20,000 enterprise users from over 50 countries, connecting more than 100 million IoT devices worldwide. Trusted by over 300 customers in business-critical production environment, EMQ powers the future-proof IoT solutions and enterprise digital transformation.

Grand Voyage Holdings

Series B in 2020
Grand Voyage Holdings is a lighting device producer and retailer. They serve traditional light source lamps and LED lamps with analog or digital control products. They focus on improving the livability and effectiveness of indoor and outdoor environments.

Yonghui Fresh Food

Series B in 2020
Yonghui Fresh Food operates as a supply chain integration platform specializing in fresh food and agricultural products. The company focuses on delivering timely supply chain services to a diverse range of customers, addressing their various purchasing needs. By streamlining food management and supply chain processes, Yonghui Fresh Food supports enterprises within the food industry, ensuring efficient access to fresh products.

Zilliz

Series B in 2020
Zilliz is a prominent vector database company based in San Francisco, California, founded in 2016. It specializes in developing advanced data processing platforms that leverage artificial intelligence and big data technologies. Zilliz is known for Milvus, an open-source vector database designed to facilitate the creation of AI and machine learning applications. By simplifying complex data infrastructure management, the company aims to enable organizations to harness the advantages of AI for a variety of applications, including computer vision, natural language processing, recommendation systems, and more. Zilliz supports over 1,000 organizations globally, helping them unlock insights from unstructured data while improving query performance through GPU hardware acceleration. Its investor backing includes notable firms such as Hillhouse Capital and Temasek's Pavilion Capital, underscoring its position in the AI and data management sectors.

Yingsheng Biology

Series B in 2020
Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development and production of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, and metabolic disorders. The company offers a diverse range of products, including 45 innovative genetic metabolic disease screening reagents, deaf genetic testing kits, and HLA-B27 detection kits. These products aim to facilitate early detection of genetic conditions and birth defects, promoting timely intervention and disease prevention. Yingsheng Bio utilizes advanced molecular diagnostic techniques and sophisticated detection systems, contributing significantly to the fields of human genetics and public health.

BioNova Pharma

Series B in 2020
BioNova Pharma biopharmaceutical company that develops and commercializes innovative medicines for cancer and other life-threatening diseases. The company is expanding company with a strong pipeline based on in-house R&D initiatives, partnerships with, and purchases from partners with cutting-edge technology. The goal of BioNova is to close the gap between the high unmet medical needs and the dearth of innovative medicines by developing an innovative R&D platform with a substantial pipeline to address multiple disease areas.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

Zhaoke Ophthalmology Pharmaceutical

Series B in 2020
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

Biren Technology

Series B in 2020
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

JD.com

Series B in 2020
JD.com, Inc., based in Beijing, is a leading e-commerce company in China, operating through its subsidiaries. It offers a wide array of products, from electronics and apparel to food and healthcare items, through its website and mobile apps. JD.com is notable for its extensive logistics network, JD Logistics, which provides efficient and reliable delivery services. The company also operates JD Health, a prominent online healthcare platform offering pharmaceuticals, medical supplies, and online consultations. JD.com's unique selling proposition lies in its self-operated logistics network, ensuring speedy and reliable delivery, and its commitment to providing authentic products. As of 2022, JD.com's gross merchandise volume (GMV) was comparable to Pinduoduo's, but still lower than Alibaba's.

Volcan Craft

Series B in 2020
Volcan Craft, also known as Shanghai Kaishan Wine Co., Ltd., is a liquor brand established in 2017 and headquartered in Shanghai, China. The company focuses on producing and selling a variety of alcoholic beverages, catering primarily to the tastes of young consumers. Volcan Craft employs a hybrid business model that combines both online and offline sales channels to enhance accessibility and engagement with its target market. Through its innovative approach, the brand aims to establish a strong presence in the competitive liquor industry.

Baijia Food

Series B in 2020
Baijia Food specializes in the research and development, manufacturing, and marketing of healthy convenience foods and compound condiments. The company offers a diverse range of products, including non-fried instant noodles, instant vermicelli, instant rice noodles, self-heating food, and self-cooking noodles. Additionally, Baijia Food provides self-heating hot pots and rice, alongside Sichuan flavor compound seasonings, allowing customers to enjoy flavorful meals in a matter of minutes.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.

Tongyu

Series B in 2020
Shanghai Tongyu Information Technology Co., Ltd. specializes in providing financial derivatives trading solutions, established in 2016 and located in Shanghai, China. The company's platform addresses the infrastructure needs of the financial derivatives market in China by supporting traders with comprehensive tools for front, middle, and back-end trading. Tongyu offers critical services such as market data, pricing, risk control technical support, as well as liquidation and delivery tools, thereby enhancing the trading experience for financial derivatives traders.

IASO Biotherapeutics

Series B in 2020
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company established in 2017 and located in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies aimed at treating cancer. IASO Biotherapeutics is particularly focused on engineered autologous and allogenic T cell therapies, which are designed to enhance the immune system's capability to identify and eliminate cancer cells. Through its research and development efforts, the company aims to provide effective cancer treatments that leverage the body's own immune response.

Transcenta Holding

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company focused on the research, development, and manufacturing of antibody-based therapeutics. Established in 2019 and headquartered in Suzhou, China, the company operates additional facilities in Shanghai, Hangzhou, Beijing, Waltham, and Princeton. Transcenta's integrated approach encompasses the discovery and development of innovative antibodies aimed at addressing various medical conditions, particularly in oncology and specific non-oncology areas such as bone and kidney disorders. The company is currently advancing nine therapeutic antibody molecules through clinical development, underscoring its commitment to improving patient outcomes. Transcenta was formed through the merger of HJB and MabSpace Biosciences, positioning it as a significant player in the global biopharmaceutical landscape.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base with an additional subsidiary in Chengdu, specializes in high-speed and high-precision radiology imaging. The company focuses on the development of static CT, X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision created China's first self-developed CMOS flat panel detector, known as the Merak series. Its products are applicable in various sectors, including medical, industrial, and security, offering advanced technological support both domestically and internationally. With a significant research and development foundation, Nanovision is positioned as a key player in the radiation imaging industry.

Elpiscience Biopharmaceuticals

Series B in 2019
Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Boke Software

Series B in 2019
Boke Information Co., Ltd. specializes in the research and development of management software and offers management consultancy services in China. The company focuses on creating logistics management solutions that enhance supply chain efficiency through the application of artificial intelligence and machine learning technologies. Boke provides implementation and maintenance services for its software products, catering to various enterprises, government entities, and community organizations. Its innovative approach emphasizes personalized software solutions designed for autonomous configuration, self-expansion, and autonomous maintenance. By supporting clients throughout the entire lifecycle of their IT systems, Boke assists in establishing comprehensive organizational frameworks and ecological structures tailored to their specific needs.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Golden Technology

Series B in 2019
Golden Technology is a big data service company based in China that specializes in providing electronic invoicing solutions through blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform designed to serve various sectors, including grocery retailers, parking lots, and restaurants. Its platform offers a range of services such as electronic invoicing, reimbursement, record-keeping, and transaction inspection and management. By leveraging blockchain, Golden Technology aims to provide convenient and cost-effective alternatives to traditional paper-based receipts, enhancing the efficiency and transparency of financial transactions.

Fapiaoer

Series B in 2019
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

CRED

Series B in 2019
CRED is a members-only credit card management and bill payments platform that rewards users every time they pay their credit card bills. The fintech startup operates an app that rewards customers for paying their credit card bills on time and gives them access to a range of additional services such as credit and a premium catalog of products from high-end brands. Customers are offered a range of features which include the ability to better track spending across various credit cards, and get reminders. Cred is backed by investors such as Falcon Edge Capital, Coatue Management, Insight Partners, DST Global, RTP Global, Tiger Global, Greenoaks Capital, Dragoneer Investment Group, and Sofina. It was established in Bengaluru, Karnataka by Kunal Shah in 2017.

Coalition

Series B in 2019
Coalition, Inc. is an insurance provider based in San Francisco, California, specializing in cyber risk management. Founded in 2017, the company offers a blend of comprehensive insurance coverage and proactive cybersecurity tools tailored for various industries, including healthcare, retail, technology, and more. Coalition's Active Risk Platform equips businesses with automated security alerts, threat intelligence, and expert guidance to enhance their resilience against cyber threats. By integrating risk assessment, security protection, and response capabilities, Coalition enables organizations to effectively mitigate and prevent potential cyber-attacks and associated losses. The company serves clients in the United States and Canada while providing its security solutions globally, supported by prominent global insurers.

Yunshuxie

Series B in 2019
Yunshuxie is a provider of comprehensive reading and writing solutions tailored for K-12 students in China. The company operates an online platform that archives and organizes a wide range of Chinese literature, creating a structured curriculum to enhance students' reading and writing skills. By integrating offline classroom experiences with online reading clubs, Yunshuxie delivers a holistic approach to literature education, serving over 2 million students. The platform is designed to facilitate both learning and practice in Chinese literature, ensuring that students have access to systematic and complete educational resources.

Moka

Series B in 2019
Moka is a software-as-a-service (SaaS) company that specializes in optimizing recruitment processes for businesses. Its platform leverages machine learning algorithms and artificial intelligence to analyze resumes and identify key characteristics of job seekers. By utilizing local semantic analysis and pattern matching, Moka effectively summarizes recruitment behavior data and conducts extensive statistical analysis. This enables organizations to gain insights into industry trends and refine their candidate selection process. The platform automates candidate screening and makes recommendations, allowing recruiters to post job listings across various platforms with ease. Moka aims to enhance recruitment effectiveness by helping companies identify suitable candidates more accurately and efficiently.

Horizon Robotics

Series B in 2019
Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Songshu Pinpin

Series B in 2019
Songshu Pinpin is an e-commerce platform focused on group buying, primarily utilizing the WeChat app to facilitate community-based orders. The platform provides high-quality daily necessities at competitive prices, catering to families in various communities. By allowing users to place orders collectively, Songshu Pinpin simplifies the purchasing process and enhances the shopping experience. Orders are processed efficiently and delivered to designated pick-up locations within the community, ensuring convenience for users.

Haihe Biopharma

Series B in 2019
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.

MatchU

Series B in 2018
MatchU is an online clothing customization platform that leverages artificial intelligence to create tailored apparel for its customers. The company focuses on addressing challenges in the clothing sector by utilizing innovative technology to measure individual body dimensions accurately. This approach allows MatchU to offer a range of customized clothing options, including shirts, suits, pants, coats, and polo shirts, ensuring that each item fits perfectly and meets the unique preferences of the user. By prioritizing customer needs and employing advanced technology, MatchU aims to deliver high-quality, personalized clothing solutions.

NextCure

Series B in 2018
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, that specializes in the discovery and development of novel immunomedicines aimed at treating cancer and other immune-related diseases. The company focuses on restoring normal immune function through its lead product candidate, NC318, currently in Phase 2 clinical trials for advanced or metastatic solid tumors. In addition, NextCure is developing NC410, an immunomedicine designed to inhibit immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1. The company's research also includes preclinical programs targeting various immunomodulatory proteins associated with tumors and inflamed tissues. NextCure has established collaborations, including a licensing agreement with Yale University and a research partnership with Eli Lilly and Company, to further its innovative therapeutic approaches. Founded in 2015, NextCure is dedicated to advancing first-in-class immunotherapy solutions.

eRoad Software

Series B in 2018
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated Mobile and Employee Services platform, with a particular emphasis on payroll solutions tailored for mid-to-large sized enterprises. Its innovative "HR+ business data" model enables organizations to analyze human effectiveness and cost efficiency, thereby enhancing operational efficiency and improving business insights. The platform supports the entire employee lifecycle, encompassing functions such as recruiting, onboarding, payroll management, benefits administration, workforce management, performance management, and talent management, making it a comprehensive solution for organizations seeking to optimize their human resource processes.

Bianlifeng

Series B in 2018
Bianlifeng is an operator of cashier-free convenience stores, specializing in intelligent 24-hour service. The company focuses on providing a seamless shopping experience through its network of staff-less stores and smart vending machines. Leveraging advanced big data and artificial intelligence, Bianlifeng aims to enhance daily shopping for customers, making it easier and more convenient. The team behind Bianlifeng is composed of industry veterans from the convenience store sector and experienced professionals from the technology field, ensuring a blend of operational expertise and innovative solutions.

XforcePlus

Series B in 2018
XforcePlus is a company specializing in enterprise collaborative software solutions delivered as a service. It focuses on providing internet-based and cloud-innovated software for supply chain collaboration and invoice management. The company's offerings include comprehensive tools for supply chain settlement, real-time electronic account management, VAT invoicing, electronic billing, payment reconciliation, tax reporting, and tax analysis. By utilizing XforcePlus's software, businesses can enhance their invoicing and taxation efficiency, ultimately improving financial security and capital management.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, that specializes in developing innovative solutions for urology. Founded in 2014, the company focuses on its flagship product, Optilume, a drug-coated balloon (DCB) catheter designed to treat urethral strictures in men. This minimally invasive device combines balloon dilation with localized drug delivery, utilizing paclitaxel to prevent the recurrence of strictures by limiting cell proliferation and fibrotic scar tissue formation. Urotronic aims to provide urologists and patients with a cost-effective alternative to traditional treatment methods, improving outcomes for individuals suffering from urinary tract conditions.

Xpeng Motors

Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.

Xiangwushuo

Series B in 2018
Xiangwushuo is a Beijing-based company that operates an online platform for the buying and selling of unused items. It facilitates the trading of new and idle goods through a unique marketplace that employs a point system, allowing users to exchange items without the need for actual currency. In addition to individual transactions, Xiangwushuo offers business owners the opportunity to promote and sell their products online, enhancing the platform's functionality as a comprehensive marketplace for both personal and commercial goods.

Omniome

Series B in 2018
Omniome, Inc. is a biotechnology company based in San Diego, California, focused on developing a DNA sequencing platform that aims to deliver high accuracy in clinical sequencing. Founded in 2013, the company utilizes its proprietary Sequencing By Binding technology, which enhances nucleotide and DNA matching by harnessing the natural capabilities of polymerase. This innovative approach allows researchers to obtain accurate and rapid sequencing results at a lower cost, with the potential to significantly advance cancer diagnostics. Omniome is supported by prominent life sciences venture investors and is committed to becoming a trusted leader in the field of DNA sequencing.

Gossamer Bio

Series B in 2018
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.

Airwallex

Series B in 2018
Airwallex is a global payments and financial platform that aims to streamline international transactions for businesses by eliminating the complexities and costs associated with traditional financial systems. The company offers a comprehensive suite of services, including payment processing, treasury management, and spend management, all integrated into a single platform. By leveraging an ecosystem of application programming interfaces, automation, and local payment networks, Airwallex enables clients to issue and pay invoices in their preferred currencies at mid-market foreign exchange rates. The platform is designed to support entrepreneurs and businesses in achieving their global objectives by providing seamless access to financial tools and opportunities worldwide.

Hangzhou Just Biotherapeutics

Series B in 2018
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.

BorderX Lab

Series B in 2018
BorderX Lab Inc. is a technology company based in Sunnyvale, California, that specializes in cross-border e-commerce solutions. Founded in 2014, it operates a demand-side platform that connects merchants from various countries, particularly the US and Europe, directly with Chinese consumers. Its flagship product, The Beyond App, serves as a mobile marketplace that leverages big data and artificial intelligence to enhance the shopping experience for affluent Chinese shoppers. The platform allows these consumers to access products and services from global brands without intermediaries, ensuring authenticity and competitive pricing. By curating advertising content, BorderX Lab helps brands effectively engage with the Chinese market while providing a seamless shopping experience for its users.

CStone Pharmaceuticals

Series B in 2018
CStone Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing and commercializing innovative immuno-oncology and molecularly targeted drugs aimed at addressing significant unmet medical needs in cancer treatment. Founded in 2015 and headquartered in Shanghai, China, the company has established a robust product pipeline that includes several late-stage clinical candidates, such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, which targets programmed death receptor. Other notable products include ivosidenib, avapritinib, and pralsetinib, along with a variety of additional investigational drugs for solid tumors and other cancer indications. CStone engages in strategic collaborations, including a licensing agreement with Numab Therapeutics for a tri-specific antibody and a clinical partnership with Bayer HealthCare to assess the efficacy of CS1001 in combination therapies. The company aims to enhance treatment options for cancer patients both in China and globally through its dedicated research and development efforts.

Beyond

Series B in 2018
Beyond is a fashion and beauty discovery app that connects Chinese brands and retailers with international brands and retailers. The platform sells women's apparel, purses, shoes, cuisine, accessories, health care, and other items. Users can use their smartphones to discover, browse, and buy using the app.

TCR2

Series B in 2018
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company based in Cambridge, Massachusetts, focused on developing innovative T cell receptor therapies for cancer treatment. The company's leading product candidates include TC-210, a TRuC-T cell therapy targeting mesothelin-positive solid tumors, which is currently undergoing phase I/II clinical trials for various cancers, including non-small cell lung cancer, ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Another candidate, TC-110, targets CD19-positive B-cell hematological malignancies. TCR2's pipeline also addresses adult acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma. Founded in 2015 by Dr. Patrick Baeuerle and MPM Capital, TCR2 leverages extensive expertise in T cell biology to create differentiated therapies that stand apart from traditional CAR-T cell treatments.

Linezone Data

Series B in 2018
LineZone Data is a technology company that specializes in data analysis, focusing on big data and artificial intelligence. The company develops solutions aimed at optimizing corporate supply chains by leveraging advanced data analytics. Through its innovative technologies, LineZone Data provides clients with intelligent business models and operational recommendations, which help improve decision-making and enhance operational efficiency.

YAOKING.CN

Series B in 2018
YAOKING.CN is a supplier of health care products. They provide products that include daily inspections, wheelchairs, crutches, and oxygen concentrator ventilators. They offer products that are available for shopping online. Their customers' inquiries are addressed through phone, email, and online applications.

BESTORE

Series B in 2017
Bestore is an e-commerce platform and online food community that provides snack items. Bestore provides leisure food production, processing, and packaging, as well as retail services. They provide products for fruits, seafood, meat, and nut snacks, covering meat snacks, roasted nuts, confectionery, dried fruit and preserved fruits, and vegetarian cherries.

Neon Therapeutics

Series B in 2017
Neon Therapeutics is a clinical-stage biopharmaceutical company specializing in neoantigen-targeted therapies aimed at advancing cancer treatment. By focusing on the immune system's response to neoantigens, the company seeks to develop innovative therapies that enhance the body's ability to fight cancer. Its product pipeline includes NEO-PV-01, NEO-PTC-01, and NEO-SV-01, which are designed to leverage the unique characteristics of neoantigens to improve patient outcomes.

Energy Monster

Series B in 2017
Energy Monster is a power bank rental service operating under Shanghai Zhi Technology, designed to offer users convenient mobile device charging solutions. The company enables customers to rent power banks easily by scanning QR codes, allowing them to maintain connectivity without interruptions. With a presence in 100 cities and partnerships with approximately 100,000 merchants, Energy Monster has established an extensive network of points of interest, including entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Users can rent power banks through mini-programs and return them at various locations, providing a flexible and accessible charging option.

Codemao

Series B in 2017
Codemao is an online education platform focused on teaching children computer coding through an engaging and interactive approach. Founded in 2015 by Tianchi Li and Yue Sun in Shenzhen, Guangdong, the platform utilizes a proprietary visual programming tool that allows students to create games, software, animations, and stories. By incorporating gamification into its curriculum, Codemao aims to make learning programming enjoyable and effective, catering to the unique learning characteristics of children. The platform not only emphasizes programming skills but also fosters logical thinking, creativity, and teamwork among young learners. Through its dynamic online community and game-based courses, Codemao provides a comprehensive educational experience that combines digital knowledge with various disciplines.

Yunzhangfang

Series B in 2017
Nanjing Yunzhangfang Network Technology Co., Ltd., established in 2015 and headquartered in Nanjing, China, specializes in providing financial and accounting software solutions tailored to enterprises, particularly micro-enterprises and small accounting agencies. The company offers automated fiscal and taxation solutions through a SaaS-based platform, streamlining essential tasks such as data collection, account verification, and tax statement preparation. With additional headquarters in Beijing and branches across various regions including Shanghai, Shenzhen, and Guangdong, Yunzhangfang aims to enhance efficiency in finance and tax management, allowing clients to manage their bookkeeping processes seamlessly from a single platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.